Filter posts

BioCentury TV This Week: 340B Drug Discount Program Needs More Oversight

BIO’s Laurel Todd shared concerns that the 340B program has departed significantly from its original …

Beggar-Thy-Neighbor Medicine: Wall Street Journal Op-Ed

In an editorial about specialty drug prices, the Wall Street Journal writes: “To understand how …

The 'What's the Point' Category for GMO Labeling Bills

Lawmakers have so much work to do, and few days left in which to do …

BIO Highlights the Importance of Care and Use of Animals at 2014 Livestock Biotech Summit

The 2014 Summit will be held September 16-19, 2014, in Sioux Falls, South Dakota at …

Synthetic Biology: The Sword in the Stone to Defeat Devastating Diseases

On July 17th, 2014 the House held a hearing titled: Subcommittee on Research and Technology …

Partnering Trends in Latin America

If phonetics were the only driver, BRIC would be CRIB. But life sciences drug-related deal-making …